Researchers work to diversify clinical trials of COVID-19 vaccine
Share Now on:
Pfizer has announced it saw good early data on results for a COVID-19 vaccine. But once a vaccine is fully tested and ready to distribute, will people be willing to get it?
A recent poll from the Kaiser Family Foundation and ESPN’s The Undefeated found that nearly half of Black adults and 37% of Latinx adults said they wouldn’t take a coronavirus vaccine, even if scientists recommend it, and it’s free.
Getting Black and Latinx communities to participate in medical research means overcoming decades of mistrust, but it’s crucial for making a product that people have faith in.
Dr. Valeria Cantos is recruiting people from the Latinx community to test a COVID-19 vaccine by drug-maker Moderna at Emory University in Atlanta.
There are some questions she gets a lot: “’You’re not going to share this information with immigration are you?’ or ‘Can I still participate if I don’t have a Social Security number?’ implying that they may be undocumented,” she said.
Cantos, who’s Latina, explains that privacy rules protect research participants, regardless of immigration status.
“Our goal is to have a vaccine that has been tested in the population that is the most vulnerable to becoming infected with COVID,” she said.
The Centers for Disease Control and Prevention says Black, Latinx and Native American people are more likely to be hospitalized and die from coronavirus infection.
Emory’s research budget has specific funds dedicated to reaching out to Black and Latinx communities. And it’s paid off: Most of the participants at the research site run by Dr. Colleen Kelley are from those groups.
“If we have a very homogenous white population involved in our clinical trials, that creates a lot of uncertainty but also mistrust around the results and how they might apply to Black and Latinx populations,” Kelley said.
That mistrust has been built over centuries from when slavery started in the colonies that became the U.S., said Dr. James Hildreth, president of the historically Black Meharry Medical College in Nashville.
“The truth is going all the way back to 1619 there is a history of atrocities being visited upon Black bodies in the service of medical research,” Hildreth said.
Hildreth is trying to broadcast his trust in research by publicly participating in a COVID-19 vaccine trial. He said people need to have faith in the vaccines to get them if they become widely available, because vaccines don’t save lives, vaccinations do.
COVID-19 Economy FAQs
Are states ready to roll out COVID-19 vaccines?
Claire Hannan, executive director of the nonprofit Association of Immunization Managers, which represents state health officials, said states have been making good progress in their preparations. And we could have several vaccines pretty soon. But states still need more funding, she said. Hannan doesn’t think a lack of additional funding would hold up distribution initially, but it could cause problems down the road. “It’s really worrisome that Congress may not pass funding or that there’s information circulating saying that states don’t need additional funding,” she said.
How is the service industry dealing with the return of coronavirus restrictions?
Without another round of something like the Paycheck Protection Program, which kept a lot of businesses afloat during the pandemic’s early stages, the outlook is bleak for places like restaurants. Some in the San Francisco Bay Area, for example, only got one week of indoor dining back before cases rose and restrictions went back into effect. Restaurant owners are revamping their business models in an effort to survive while waiting to see if they’ll be able to get more aid.
How are hospitals handling the nationwide surge in COVID-19 cases?
As the pandemic surges and more medical professionals themselves are coming down with COVID, nearly 1 in 5 hospitals in the country report having a critical shortage of staff, according to data from the Department of Health and Human Services. One of the knock-on effects of staff shortages is that people who have other medical needs are being asked to wait.
As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.
Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.
Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.